The post-transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase-Reference-Cited by-同舟云学术

The post-transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase

Published:2002-08-15 Issue:3 Volume:118 Page:762-770
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Olavarria Eduardo,Reiffers Josy,Boque Concha,Sureda Ana,Meloni Giovanna,Michallet Mauricette,Clark Richard E.,Blaise Didier,Carella Angelo M.,Cahn Jean-Yves,Jouet Jean P.,Rizzoli Vittorio,Van Biezen Anja,Gratwohl Alois,Goldman John M.,Niederwieser Dietger,Apperley Jane F.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03600.x/fullpdf

Reference51 articles.

1. UK Medical Research Council randomised, multicentre trial of interferon-alfa for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response;Allan;Lancet,1995

2. Analysis of survival by tumor response;Anderson;Journal of Clinical Oncology,1983

3. Hematopoietic stem cell transplantation in chronic myeloid leukemia;Apperley;Current Opinion in Hematology,1998

4. Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study;Barnett;Blood,1994

5. Autologous transplantation for the treatment of chronic myelogenous leukemia;Bhatia;Hematology Oncology Clinics of North America,1998

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Autologous Hematopoietic Stem Cell Transplantation: Safety, Efficacy, and Patient Outcomes. Literature Review;Pediatric Health, Medicine and Therapeutics;2023-05

2. Hematopoietic Stem Cell Transplantation for Chronic Myeloid Leukemia;Thomas’ Hematopoietic Cell Transplantation;2016-01-01

3. Autologous Stem Cell Transplantation in Chronic Myeloid Leukemia;Seminars in Hematology;2007-10

4. High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study;Annals of Hematology;2006-10-10

5. Chronic Myelogenous Leukemia;Wiley Handbook of Current and Emerging Drug Therapies;2006-09-15